Literature DB >> 8094339

Differential laminar expression of particulate and soluble guanylate cyclase genes in rat retina.

I Ahmad1, C J Barnstable.   

Abstract

Expression of both particulate and soluble forms of guanylate cyclase have been identified in adult rat retina using reverse transcriptase-PCR amplification of retinal RNA and sequencing of the cloned cDNAs. Over a 267-amino acid region, the retinal particulate guanylate cyclase was found to be identical in sequence to the GC-A form of the enzyme found in many tissues. No expression of the closely related GC-B or GC alpha forms of the enzyme was found. mRNA corresponding to both subunits of the soluble form of guanylate cyclase were detected in retinal. The sequence corresponding to the 70-kDa subunit was identical to that from rat lung over a 304-amino acid region and the sequence corresponding to the 82-kDa subunit showed only one amino acid difference over a 275-amino acid region. From Northern analyses the level of expression of the soluble guanylate cyclase in retina was higher than that in lung. In situ hybridization to sections of adult retina indicated that the particulate guanylate cyclase was expressed predominantly in rod photoreceptors. Although the soluble form of the enzyme was detected in all retinal layers, the level of expression was much higher in the inner nuclear layer. The results suggest that multiple enzymes and hence multiple regulatory pathways may control cGMP levels in rod photoreceptors and that cGMP may play an important role in neurons of the inner retina.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094339     DOI: 10.1006/exer.1993.1008

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  16 in total

Review 1.  Soluble guanylate cyclases in the retina.

Authors:  Ari Sitaramayya
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  cGMP-dependent kinase regulates response sensitivity of the mouse on bipolar cell.

Authors:  Josefin Snellman; Scott Nawy
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

Review 3.  Regulation of ON bipolar cell activity.

Authors:  Josefin Snellman; Tejinder Kaur; Yin Shen; Scott Nawy
Journal:  Prog Retin Eye Res       Date:  2008-04-06       Impact factor: 21.198

4.  cGMP-mediated effects on the physiology of bovine and human retinal Müller (glial) cells.

Authors:  S Kusaka; I Dabin; C J Barnstable; D G Puro
Journal:  J Physiol       Date:  1996-12-15       Impact factor: 5.182

5.  Neuronal isoform of nitric oxide synthase is expressed at low levels in human retina.

Authors:  C S Park; C Gianotti; R Park; G Krishna
Journal:  Cell Mol Neurobiol       Date:  1996-08       Impact factor: 5.046

6.  Cloning and expression of a second photoreceptor-specific membrane retina guanylyl cyclase (RetGC), RetGC-2.

Authors:  D G Lowe; A M Dizhoor; K Liu; Q Gu; M Spencer; R Laura; L Lu; J B Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

7.  The nitric oxide-cGMP signaling pathway differentially regulates presynaptic structural plasticity in cone and rod cells.

Authors:  Nan Zhang; Annie Beuve; Ellen Townes-Anderson
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

8.  Localisation of neuronal nitric oxide synthase-immunoreactivity in rat and rabbit retinas.

Authors:  M T Perez; B Larsson; P Alm; K E Andersson; B Ehinger
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

9.  Rat hippocampal neurons express genes for both rod retinal and olfactory cyclic nucleotide-gated channels: novel targets for cAMP/cGMP function.

Authors:  P A Kingston; F Zufall; C J Barnstable
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Inhibition of nitric oxide synthase desensitizes retinal ganglion cells to light by diminishing their excitatory synaptic currents under light adaptation.

Authors:  Joseph P Nemargut; Guo-Yong Wang
Journal:  Vision Res       Date:  2009-09-20       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.